Icahn's Biogen Takeover: Denner's North Korea Quip

Icahn's Biogen Takeover: Denner's North Korea Quip

When last we left the cliffhanger that was yesterday's Biogen Idec (NASDAQ: BIIB) annual meeting: the forces of billionaire investor Carl Icahn claimed they had won two of four director seats up for election. The New York Times was reporting Icahn had secured at least one place, and Biogen itself had adjourned the meeting saying results of the vote were not yet clear and would be announced later this month.

Popular in the Community

Close

What's Hot